C. B. Levy

Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors.

V. L. Rath, F. Nuttall, Carolyn B Levy, 2005, American journal of physiology. Endocrinology and metabolism.

Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.

Carolyn B Levy, R. McPherson, J. Treadway, 2000, Diabetes.

Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography.

M. Mansour, D. Danley, G. Schulte, 2002, Journal of medicinal chemistry.

Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.

Carolyn B Levy, R. McPherson, J. Treadway, 1998, Diabetes.

The Sulfonylurea Glipizide Does Not Inhibit Ischemic Preconditioning in Anesthetized Rabbits

Carolyn B Levy, W. Soeller, J. Treadway, 2005, Cardiovascular Drugs and Therapy.

5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.

V. L. Rath, S. Wright, D. Hageman, 2005, Bioorganic & medicinal chemistry letters.

Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.

Carolyn B Levy, R. McPherson, J. Treadway, 2004, American journal of physiology. Heart and circulatory physiology.